Skip to main content

NICE supports age discrimination

From the National Institute for Health and Clinical Excellence (see link)

Draft proposals for health rationing.
Recommendation 6
With respect to age (section 5.1):
• however, where age is an indicator of benefit or risk, age discrimination
is appropriate.

Recommendation 7
When setting priorities there is no case for discrimination on the basis of
gender or sexual orientation unless these are risk factors for benefits, risks, or
both (section 5.2).

Recommendation 14
Priority for patients with conditions associated with social stigma should only
be considered if the additional psychological burdens have not been
adequately taken into account in the cost–utility analyses (section 6.5).


The above recommendations raise a number of issues, not least the question as to exactly when "age discrimination is appropriate". I can understand the risk issue, but the benefit issue is not clear.

What I have difficulty understanding is what "risk factors for benefits, risks or both" exist for gender or sexual orientation discrimination.

Perhaps the most significant is, however:
Recommendation 5
NICE guidance should explain, explicitly, reasons for recommending – as cost
effective – those interventions with an incremental cost-effectiveness ratio
over £20,000 to £30,000 per QALY (section 4.3).


(A QALY is a Quality Adjusted Life Year).

Comments

Popular posts from this blog

Its the long genes that stop working

People who read my blog will be aware that I have for some time argued that most (if not all) diseases of aging are caused by cells not being able to produce enough of the right proteins. What happens is that certain genes stop functioning because of a metabolic imbalance. I was, however, mystified as to why it was always particular genes that stopped working. Recently, however, there have been three papers produced: Aging is associated with a systemic length-associated transcriptome imbalance Age- or lifestyle-induced accumulation of genotoxicity is associated with a generalized shutdown of long gene transcription and Gene Size Matters: An Analysis of Gene Length in the Human Genome From these it is obvious to see that the genes that stop working are the longer ones. To me it is therefore obvious that if there is a shortage of nuclear Acetyl-CoA then it would mean that the probability of longer Genes being transcribed would be reduced to a greater extent than shorter ones.